Galectin Therapeutics, Inc. (GALT)
3.90
+0.14
(+3.72%)
USD |
NASDAQ |
Oct 02, 16:00
3.85
-0.05
(-1.28%)
After-Hours: 20:00
Galectin Therapeutics Market Cap : 258.62M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 258.62M |
| October 01, 2026 | 249.33M |
| September 30, 2026 | 257.29M |
| September 29, 2026 | 259.28M |
| September 28, 2026 | 260.61M |
| September 25, 2026 | 258.62M |
| September 24, 2026 | 262.60M |
| September 23, 2026 | 268.56M |
| September 22, 2026 | 274.53M |
| September 21, 2026 | 262.60M |
| September 18, 2026 | 257.95M |
| September 17, 2026 | 246.02M |
| September 16, 2026 | 244.03M |
| September 15, 2026 | 247.34M |
| September 14, 2026 | 254.64M |
| September 11, 2026 | 259.28M |
| September 10, 2026 | 258.62M |
| September 09, 2026 | 268.56M |
| September 08, 2026 | 274.53M |
| September 04, 2026 | 305.70M |
| September 03, 2026 | 288.46M |
| September 02, 2026 | 297.08M |
| September 01, 2026 | 276.52M |
| August 31, 2026 | 261.93M |
| August 28, 2026 | 266.57M |
| Date | Value |
|---|---|
| August 27, 2026 | 274.53M |
| August 26, 2026 | 275.19M |
| August 25, 2026 | 264.58M |
| August 24, 2026 | 257.29M |
| August 21, 2026 | 244.03M |
| August 20, 2026 | 236.73M |
| August 19, 2026 | 243.36M |
| August 18, 2026 | 233.42M |
| August 17, 2026 | 232.75M |
| August 14, 2026 | 228.11M |
| August 13, 2026 | 234.08M |
| August 12, 2026 | 208.22M |
| August 11, 2026 | 207.56M |
| August 10, 2026 | 205.47M |
| August 07, 2026 | 227.21M |
| August 06, 2026 | 212.06M |
| August 05, 2026 | 203.50M |
| August 04, 2026 | 196.58M |
| August 03, 2026 | 199.55M |
| July 31, 2026 | 195.60M |
| July 30, 2026 | 212.72M |
| July 29, 2026 | 229.84M |
| July 28, 2026 | 223.25M |
| July 27, 2026 | 222.60M |
| July 24, 2026 | 228.52M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Mirum Pharmaceuticals, Inc. | 5.370B |
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
| Vericel Corp. | 2.055B |
Market Cap Related Metrics
| Price | 3.90 |
| Earnings Yield | -11.02% |